Evidence map›Paper›PMID 41767268›Full record

ArticleiScience2026

Machine learning models for early mortality prediction in severe fever with thrombocytopenia syndrome.

Chenxi Zhao, Tingyu Zhang, Ziruo Ge, Ling Lin, Di Tian, Yi Shen, Zhenghua Zhao, Jingxia Wang, Jianming Lai, Yanli Xu and 2 more

Abstract read
In one paragraph

Article in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Chenxi ZhaoNational Key Laboratory of Intelligent Tracking and Forecasting for infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China.
Tingyu ZhangNational Key Laboratory of Intelligent Tracking and Forecasting for infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China.
Ziruo GeNational Key Laboratory of Intelligent Tracking and Forecasting for infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China.
Ling LinDepartment of Infectious Diseases, Yantai Qishan Hospital, Yantai, Shandong Province 264001, China.
Di TianNational Key Laboratory of Intelligent Tracking and Forecasting for infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China.
Yi ShenDepartment of Infectious Diseases, Dandong Infectious Disease Hospital, Dandong, China.
Zhenghua ZhaoDepartment of Infectious Disease, Tai'an City Central Hospital, Qingdao University, Tai'an, Shandong Province 271000, China.
Jingxia WangNational Key Laboratory of Intelligent Tracking and Forecasting for infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China.
Jianming LaiDepartment of Infectious Diseases, The Sixth People's Hospital of Qingdao, Tai'an, Shandong Province 266033, China.
Yanli XuDepartment of Infectious Diseases, Yantai Qishan Hospital, Yantai, Shandong Province 264001, China.
Jianping DuanDepartment of Infectious Diseases, The Sixth People's Hospital of Qingdao, Tai'an, Shandong Province 266033, China.
Zhihai ChenNational Key Laboratory of Intelligent Tracking and Forecasting for infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Severe fever with thrombocytopenia syndrome (SFTS) is a high-fatality viral disease where early mortality risk prediction is vital for clinical management. This retrospective multicenter cohort study enrolled 1,690 hospitalized SFTS patients from five Chinese hospitals (2014-2023) to develop, validate, and deploy an interpretable machine learning (ML) model for early mortality risk assessment. Using LASSO regression for feature selection then comparing eight ML algorithms, the XGBoost model achieved an AUC of 0.916 in the training cohort and 0.905 in the temporal validation cohort. SHapley Additive exPlanations (SHAP) analysis identified six key predictors, which were used to deploy a real-time, open-access web-based tool (https://sftsprognosis.com) that provides individualized risk predictions with visual explanations. The XGBoost model has the potential to enhance timely clinical decision-making, facilitate efficient allocation of critical care resources, and provide a generalizable framework for applying machine learning in the management of emerging infectious diseases.

Indexed as

artificial intelligence applicationspublic health

Identifiers

PMID41767268
PMCPMC12936484

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.